Does statin use affect the risk of developing prostate cancer?
Related Experiment Video
Updated: Jun 26, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. eplatz@jhsph.edu
Abstract:
This commentary discusses the findings of Agalliu and colleagues, who performed a population-based, case-control study on the association between statin drugs and prostate cancer risk. Consistent with recent studies, statins were not associated with overall prostate cancer risk, but users had a possible lower risk of advanced disease. Obese men taking a statin had a higher risk of prostate cancer than those not taking a statin; however, a previously conducted, large, prospective, cohort study did not observe this association. This unexpected finding by Agalliu et al. could be a chance result, or could have arisen because of complex bias. Although statins might favorably affect men's prostate health, evidence is too limited to recommend statin use for the prevention of advanced prostate cancer. Consideration of the harms and benefits when prescribing a statin for vascular indications, including in obese men, should not presently include prostate cancer risk.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Cancer Prevention
Some...
Coronary Artery Disease IV: Preventive Measures
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmacokinetics: Drug–Drug Interactions